Old Web
English
Sign In
Acemap
>
authorDetail
>
James N. Leonard
James N. Leonard
Janssen Pharmaceutica
Enteropeptidase
Chemistry
Biomarker (medicine)
Medicine
Glucagon receptor
3
Papers
10
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of a novel series of guanidinebenzoates as gut-restricted enteropeptidase and trypsin dual inhibitors for the treatment of metabolic syndrome
2021
Bioorganic & Medicinal Chemistry Letters
Xuqing Zhang
Bin Zhu
Weimei Sun
Mina Wang
Kamal Albarazanji
Brahma Ghosh
Maxwell D. Cummings
James Lenhard
James N. Leonard
Mark J. Macielag
James C. Lanter
Show All
Source
Cite
Save
Citations (0)
Amino Acids Are Sensitive Glucagon Receptor Specific Biomarkers for Glucagon‐Like Peptide 1 Receptor/Glucagon Receptor Dual Agonists
2020
Diabetes, Obesity and Metabolism
Wenyu Li
Thomas Kirchner
George Ho
Fany Bonilla
Daquino Katharine E
James Littrell
Rui Zhang
Wenying Jian
Xi Qiu
Songmao Zheng
Peggy Wong
James N. Leonard
Camacho Raul C
Show All
Source
Cite
Save
Citations (4)
Targeting enteropeptidase with reversible covalent inhibitors to achieve metabolic benefits.
2020
Journal of Pharmacology and Experimental Therapeutics
Weimei Sun
Xuqing Zhang
Maxwell D. Cummings
Kamal Albarazanji
Jiejun Wu
Mina Wang
Richard Alexander
Bin Zhu
Yue-Mei Zhang
James N. Leonard
James C. Lanter
James Lenhard
Show All
Source
Cite
Save
Citations (6)
1
map